- Home
- SVM vs CMRX Comparison
SVM vs CMRX Comparison
Compare SVM & CMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVM
- CMRX
- Stock Information
- Founded
- SVM N/A
- CMRX 2000
- Country
- SVM Canada
- CMRX United States
- Employees
- SVM N/A
- CMRX N/A
- Industry
- SVM Precious Metals
- CMRX Biotechnology: Pharmaceutical Preparations
- Sector
- SVM Basic Materials
- CMRX Health Care
- Exchange
- SVM Nasdaq
- CMRX Nasdaq
- Market Cap
- SVM 769.7M
- CMRX 797.3M
- IPO Year
- SVM N/A
- CMRX 2013
- Fundamental
- Price
- SVM $3.74
- CMRX $8.54
- Analyst Decision
- SVM Strong Buy
- CMRX Hold
- Analyst Count
- SVM 1
- CMRX 4
- Target Price
- SVM $5.10
- CMRX $8.51
- AVG Volume (30 Days)
- SVM 6.2M
- CMRX 2.0M
- Earning Date
- SVM 05-22-2025
- CMRX 04-30-2025
- Dividend Yield
- SVM 0.65%
- CMRX N/A
- EPS Growth
- SVM 104.66
- CMRX N/A
- EPS
- SVM 0.36
- CMRX N/A
- Revenue
- SVM $266,463,000.00
- CMRX $212,000.00
- Revenue This Year
- SVM $35.71
- CMRX $2,416.04
- Revenue Next Year
- SVM $10.92
- CMRX $923.92
- P/E Ratio
- SVM $11.39
- CMRX N/A
- Revenue Growth
- SVM 28.94
- CMRX N/A
- 52 Week Low
- SVM $2.87
- CMRX $0.75
- 52 Week High
- SVM $5.32
- CMRX $8.55
- Technical
- Relative Strength Index (RSI)
- SVM 49.69
- CMRX 80.86
- Support Level
- SVM $3.15
- CMRX $8.50
- Resistance Level
- SVM $4.06
- CMRX $8.55
- Average True Range (ATR)
- SVM 0.23
- CMRX 0.02
- MACD
- SVM 0.01
- CMRX -0.12
- Stochastic Oscillator
- SVM 64.84
- CMRX 88.89
About SVM Silvercorp Metals Inc.
Silvercorp Metals Inc is a mineral mining company. It acquires, explores, develops, and mines precious and base metal mineral properties at its producing mines and exploration and development projects in China. The group produces silver, gold, lead, and zinc. The company creates shareholder's value by focusing on generating free cash flow from long-life mines; organic growth through extensive drilling for discovery; equity investments in potential world-class opportunities; ongoing merger and acquisition efforts to unlock value; and long-term commitment to responsible mining and ESG. The Company's producing mines are located in China, and current exploration and development projects are located in China and Mexico.
About CMRX Chimerix Inc.
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.